Filed Oct. 15, 2026

Serial No. 50163302

Class Pharmaceutical research and development; Scientific research and development, namely, inputting, collecting, defining, modeling, analyzing, and validating data related to biomarkers for the purposes of drug development and diagnostics; Customizing computer software related to inputting, collecting, defining, modeling, analyzing, and validating data related to biomarkers for the purposes of drug development and diagnostics; Scientific research and development services in the fields of liquid biopsy, cell-free nucleic acids, cell-free RNA, cell-free DNA, proteomics, and transcriptomics; Scientific research services, namely, next-generation sequencing and profiling of cell-free RNA and cell-free DNA from blood and other bodily fluid samples for research purposes; Scientific research services, namely, proteomic profiling and analysis of proteins and peptides in blood and other bodily fluid samples for research purposes; Scientific laboratory services, namely, isolation, preparation, and analysis of nucleic acids and proteins from bodily fluid samples for research purposes; Drug discovery and development services, namely, identification and validation of biomarkers and drug targets through analysis of cell-free nucleic acids and proteins; Providing scientific research and development services to pharmaceutical and biotechnology companies in the fields of disease biology, biomarker discovery, patient stratification, and therapeutic activity assessment; Scientific research services in the field of clinical trial support, namely, biomarker analysis of patient samples for research purposes; Bioinformatics services for scientific research purposes, namely, analysis and interpretation of nucleic acid sequencing data and proteomic data; Software as a service (SaaS) services featuring software for analyzing, modeling, and visualizing cell-free nucleic acid sequencing data, proteomic data, and biomarker data for scientific research purposes; Software as a service (SaaS) services featuring software that uses artificial intelligence and machine learning for identifying disease-associated patterns in nucleic acid sequencing data and proteomic data for scientific research purposes; Providing temporary use of online non-downloadable software for collecting, managing, and analyzing biomarker data for drug development; Platform as a service (PaaS) featuring computer software platforms for biomarker data analysis for scientific research purposes; Computer software design, development, and programming services for others in the field of bioinformatics and biomarker analysis; Technological consulting services in the fields of liquid biopsy, cell-free nucleic acid analysis, proteomics, and biomarker data analysis; 100; 101; 100; 101

Case Type Service mark